Pfizer (PFE)

Investing Cash Flow

-$5.69B

TTM · Period ending: · USD

PFE logo

PFE Investing Cash Flow

Latest reported-$5.69B
PFE TTM Cash from Investing (-$329.00M → -$5.69B)
High-resolution chart · PNG

PFE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-5,930,000,000
-4,937,000,000
-3,753,000,000
-3,542,000,000
-2,754,000,000
-1,820,000,000
-2,768,000,000
-4,100,000,000
-1,630,000,000
-1,519,000,000
-335,000,000
943,000,000
-730,000,000
-530,000,000
-1,022,000,000
-552,000,000
-1,200,000,000
-1,533,000,000
-937,000,000
-1,523,200,000
-702,500,000
-413,700,000
-2,342,800,000
-2,173,600,000
-2,306,900,000
-2,421,500,000
-840,300,000
-570,300,000
-432,500,000
20,600,000
-196,900,000
62,900,000
-90,500,000
-87,700,000
389,900,000
173,600,000
210,100,000
-46,100,000
-125,200,000
-232,100,000
-344,600,000
-329,100,000
-329,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.